AI assistant
Sending…
IGC Pharma, Inc. — Director's Dealing 2017
Dec 8, 2017
34705_dirs_2017-12-08_70bcd1bc-0b5a-4697-a995-ba0530dca689.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: India Globalization Capital, Inc. (IGC)
CIK: 0001326205
Period of Report: 2017-12-07
Reporting Person: MUKUNDA RAM (Director, Exec. Chairman & CEO, 10% Owner)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2017-12-07 | Common stock | S | 70000 | $0.85 | Disposed | 2526944 | Direct |
| 2017-12-07 | Common stock | S | 30000 | $0.86 | Disposed | 2496944 | Direct |
| 2017-12-08 | Common stock | S | 9950 | $0.83 | Disposed | 2486994 | Direct |
| 2017-12-08 | Common stock | S | 10000 | $0.84 | Disposed | 2476994 | Direct |
| 2017-12-08 | Common stock | S | 10000 | $0.85 | Disposed | 2466994 | Direct |
| 2017-12-08 | Common stock | S | 5000 | $0.88 | Disposed | 2461994 | Direct |
| 2017-12-08 | Common stock | S | 15000 | $0.90 | Disposed | 2446994 | Direct |
| 2017-12-08 | Common stock | S | 5000 | $0.91 | Disposed | 2441994 | Direct |
More from IGC Pharma, Inc.
Capital/Financing Update
2026
Jun 8
Interim / Quarterly Report
2026
May 15
Capital/Financing Update
2026
Apr 20
Regulatory Filings
2026
Mar 30
Annual Report
2026
Mar 18
Director's Dealing
2026
Feb 4
Director's Dealing
2026
Jan 20
Capital/Financing Update
2026
Jan 6
Regulatory Filings
2026
Jan 2
Capital/Financing Update
2025
Dec 15